Displaying items by tag: division of endocrinology diabetes and metabolism

Use of the diabetes drug metformin — before a diagnosis of COVID-19 — was associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes.
Migraine headaches were ruining Christopher Sheheane’s life, until a visit to UAB found the cause: a pituitary gland tumor.
Patients with thyroid, parathyroid, pancreas and adrenal tumors will soon have a one-stop shop for endocrine neoplasia treatment.
UAB surgeons removed a rare pituitary gland tumor from a Cullman woman that had defied diagnosis for years.
Fernando Ovalle, M.D., has been named director of the Division of Endocrinology, Diabetes, and Metabolism at UAB.
In six decades, two patients have seen a big change in how to manage their Type 1 diabetes.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
After experiencing side effects from his obesity on a meaningful vacation, one man seeks medical attention from UAB on his weight loss journey.
Harris, who was recognized for her excellence in the clinical area of the advanced practice level, earned her master’s from UAB in 2011.
Page 1 of 2